Suchergebnisse - "Pytel, Dariusz"

PubPharm (7)

1

The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases

enthalten in: International journal of molecular sciences | 2020

von Rozpędek-Kamińska, W. | Siwecka, N. | Wawrzynkiewicz, A. | +4

2

Use of Small-molecule Inhibitory Compound of PERK-dependent Signaling Pathway as a Promising Target-based Therapy for Colorectal Cancer

enthalten in: Current cancer drug targets | 2020

von Rozpędek, W. | Pytel, D. | Wawrzynkiewicz, A. | +5

3

Potential therapeutic application of PERK inhibitors

enthalten in: Postepy biochemii | 2019

von Basak, J. | Rozpędek, W. | Pytel, D. | +1

4

PERK Is a Haploinsufficient Tumor Suppressor : Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in Melanoma

enthalten in: PLoS genetics | 2016

von Pytel, D. | Gao, Y. | Mackiewicz, K. | +12

5

Small molecule inhibitors of PERK-dependent signaling pathway as a novel, therapeutic molecular strategy in Alzheimer's disease treatment

enthalten in: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego | 2016

von Rozpędek, W. | Pytel, D. | Diehl, J. | +1

6

Unfolded Protein Response and PERK Kinase as a New Therapeutic Target in the Pathogenesis of Alzheimer's Disease

enthalten in: Current medicinal chemistry | 2015

von Rozpedek, W. | Markiewicz, L. | Diehl, J. | +2

7

Enzymatic Characterization of ER Stress-Dependent Kinase, PERK, and Development of a High-Throughput Assay for Identification of PERK Inhibitors

enthalten in: Journal of biomolecular screening | 2014

von Pytel, D. | Seyb, K. | Liu, M. | +6

1
[1]